Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis

Schizophrenia Bulletin

Volumn 39, Issue 4, 2013, Pages 830-838

  Peters, Bart D ^a,b   Machielsen, Marise W J ^a   Hoen, Wendela P ^c   Caan, Matthan W A ^a   Malhotra, Anil K ^b   Szeszko, Philip R ^b   Duran, Marinus ^d   Olabarriaga, Silvia D ^d   De Haan, Lieuwe ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c JellinekMentrum   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

diffusion tensor imaging; first episode psychosis; myelin; polyunsaturated fatty acids; schizophrenia; white matter

Indexed keywords

15 TETRACOSENOIC ACID; ARACHIDONIC ACID; ARIPIPRAZOLE; CLOZAPINE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; HALOPERIDOL; LINOLEIC ACID; MYELIN; OLANZAPINE; POLYUNSATURATED FATTY ACID; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; ERYTHROCYTE MEMBRANE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER;

EID: 84879348823     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs089     Document Type: Article

References (43)

1. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 2006; 15: 1995-2002. (Pubitemid 43983273)
2. Hodgkinson CA, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 2004; 75: 862-872. (Pubitemid 39390493)
3. Tkachev D, Mimmack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003; 362: 798-805. (Pubitemid 37093922)
4. Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res. 2002; 27: 1193-1200. (Pubitemid 35316115)
5. Peters BD, Blaas J, de Haan L. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? J Psychiatr Res. 2010; 44: 993-1004.
6. Bourre JM, Pascal G, Durand G, Masson M, Dumont O, Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem. 1984; 43: 342-348. (Pubitemid 14093559)
7. Trapp BD, Bernsohn J. Essential fatty acid deficiency and CNS myelin. Biochemical and morphological observations. J Neurol Sci. 1978; 37: 249-266. (Pubitemid 8355360)
8. Selivonchick DP, Johnston PV. Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J Nutr. 1975; 105: 288-300.
9. Salvati S, Natali F, Attorri L, et al. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res. 2008; 86: 776-784. (Pubitemid 351357759)
10. Virtanen JK, Siscovick DS, Longstreth WT Jr, Kuller LH, Mozaffarian D. Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology. 2008; 71: 439-446.
11. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand. 2000; 102: 143-149. (Pubitemid 30645133)
12. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001; 49: 510-522. (Pubitemid 32226409)
13. Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 393-399. (Pubitemid 37464048)
14. Reddy RD, Keshavan MS, Yao JK. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull. 2004; 30: 901-911. (Pubitemid 40469524)
15. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res. 2002; 58: 1-10. (Pubitemid 35287278)
16. Arvindakshan M, Sitasawad S, Debsikdar V, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry. 2003; 53: 56-64. (Pubitemid 36050936)
17. Yao JK, Leonard S, Reddy RD. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res. 2000; 42: 7-17. (Pubitemid 30116755)
18. Amminger GP, Schafer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010; 67: 146-154.
19. Peters BD, Duran M, Vlieger EJ, et al. Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset schizophrenia: a preliminary study. Prostaglandins Leukot Essent Fatty Acids. 2009; 81: 61-63.
20. Richardson AJ, Allen SJ, Hajnal JV, Cox IJ, Easton T, Puri BK. Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25: 1513-1521. (Pubitemid 33042694)
21. Yao J, Stanley JA, Reddy RD, Keshavan MS, Pettegrew JW. Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry. 2002; 52: 823-830.
22. Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ. The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain. 1999; 122(Pt 1): 99-110. (Pubitemid 29046276)
23. Olabarriaga SD, Glatard T, de Boer PT. A virtual laboratory for medical image analysis. IEEE Trans Inf Technol Biomed. 2010; 14: 979-985.
24. Caan MW, Khedoe G, Poot D, et al. Adaptive noise filtering for accurate and precise diffusion estimation in fiber crossings. Med Image Comput Comput Assist Interv. 2010; 13: 167-174.
25. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006; 31: 1487-1505.
26. Assies J, Lok A, Bockting CL, et al. Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins Leukot Essent Fatty Acids. 2004; 70: 349-356. (Pubitemid 38429267)
27. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002; 15: 435-455. (Pubitemid 36054508)
28. Hofling AA, Kim JH, Fantz CR, Sands MS, Song SK. Diffusion tensor imaging detects axonal injury and demyelination in the spinal cord and cranial nerves of a murine model of globoid cell leukodystrophy. NMR Biomed. 2009; 22: 1100-1106.
29. Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. Neuropsychopharmacology. 2007; 32: 2067-2073. (Pubitemid 47417692)
30. Hibbeln JR, Makino KK, Martin CE, Dickerson F, Boronow J, Fenton WS. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry. 2003; 53: 431-441. (Pubitemid 36263017)
31. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276. (Pubitemid 18039085)
32. Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res. 1985; 24: 69-176.
33. O'Brien JS. A molecular defect of myelination. Biochem Biophys Res Commun. 1964; 15: 484-490.
34. Yao JK, van Kammen DP. Membrane phospholipids and cytokine interaction in schizophrenia. Int Rev Neurobiol. 2004; 59: 297-326. (Pubitemid 39753905)
35. Smesny S, Kinder D, Willhardt I, et al. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia. Biol Psychiatry. 2005; 57: 399-405. (Pubitemid 40215770)
36. Bongarzone ER, Pasquini JM, Soto EF. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res. 1995; 41: 213-221.
37. Babin F, Sarda P, Limasset B, et al. Nervonic acid in red blood cell sphingomyelin in premature infants: an index of myelin maturation? Lipids. 1993; 28: 627-630. (Pubitemid 23207096)
38. Martinez M Mougan I. Fatty acid composition of human brain phospholipids during normal development. J Neurochem. 1998; 71: 2528-2533. (Pubitemid 28531264)
39. Amminger GP, Schafer MR, Klier CM, et al. Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals [published online ahead of print December 20, 2011]. Mol Psychiatry. doi: 10.1038/mp.2011.167.
40. Szeszko PR, Robinson DG, Ashtari M, et al. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology. 2008; 33: 976-984. (Pubitemid 351367538)
41. Berger GE, Wood SJ, Wellard RM, et al. Ethyleicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology. 2008; 33: 2467-2473.
42. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003; 133(Suppl 3): 925-932.
43. Bentsen H, Solberg DK, Refsum H, et al. Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder. Biol Psychiatry. 2011; 70: 97-105.